Prelude Capital Management’s Astrana Health ASTH Stock Holding History

Prelude Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Buy	+4,843	New	+$174K	0.02%	929
2025 Q4	–	Sell	-12,382	Closed	-$351K	–	1605
2025 Q3	$351K	Buy	+12,382	New	+$336K	0.03%	649
2025 Q1	–	Sell	-7,284	Closed	-$230K	–	1577
2024 Q4	$230K	Buy	+7,284	New	+$346K	0.01%	927
2021 Q4	–	Sell	-14,873	Closed	-$1.35M	–	2306
2021 Q3	$1.35M	Buy	+14,873	New	+$1.26M	0.03%	444
2020 Q4	–	Sell	-500	Closed	-$9K	–	2091
2020 Q3	$9K	Buy	+500	New	+$8.63K	﹤0.01%	1475
2019 Q1	–	Sell	-419	Closed	-$8K	–	2260
2018 Q4	$8K	Hold	419	–	–	﹤0.01%	1433
2018 Q3	$9K	Buy	+419	New	+$8.82K	﹤0.01%	1489

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Prelude Capital Management's ASTH Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Astrana Health (ASTH) in Q2 2026: 4,843 shares worth $225K. The stake represents 0.02% of the portfolio and ranks #929 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in ASTH as recently as Q3 2025.

Prelude Capital Management first reported a position in ASTH in Q3 2018 and has held it in 7 quarters since. The position peaked at $1.35M in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Prelude Capital Management held 4,843 shares of Astrana Health worth $225K as of Q2 2026.
Astrana Health was a new Prelude Capital Management position in Q2 2026.
Astrana Health made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #929 holding.
Prelude Capital Management first reported a position in Astrana Health in Q3 2018 and has held it in 7 quarters since.
Prelude Capital Management's Astrana Health position peaked at $1.35M in Q3 2021.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.